Fluticasone Propionate and Fluticasone Propionate/Salmeterol Compared to FLOVENT® DISKUS® and ADVAIR® DISKUS®

Study Title
Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENTֲ® DISKUSֲ® and ADVAIRֲ® DISKUSֲ® in Patients With Persistent Asthma 12 Years of Age and Older
Teva Identifier
FSS-AS-10042
ClinicalTrials.gov Identifier
NCT02437604
Study Status
Completed
Trial Condition(s)
Asthma
Interventions
Drug: Treatment A: Fp MDPI | Drug: Treatment B: FS MDPI | Drug: Treatment C Flovent | Drug: Treatment D: Advair

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
12 Years and older
Trial Duration
05/01/2015 - 09/01/2015
Phase
Phase 1

Study Type

Interventional